A Phase 1 Open-Label, Single-Dose, Dose Escalation Study in Healthy Subjects to Evaluate the Safety and Pharmacokinetics of Orally Administered Civamide (Zucapsaicin).

Trial Profile

A Phase 1 Open-Label, Single-Dose, Dose Escalation Study in Healthy Subjects to Evaluate the Safety and Pharmacokinetics of Orally Administered Civamide (Zucapsaicin).

Discontinued
Phase of Trial: Phase I

Latest Information Update: 09 Jun 2011

At a glance

  • Drugs Zucapsaicin (Primary)
  • Indications Cluster headache; Migraine; Musculoskeletal pain; Postherpetic neuralgia
  • Focus Pharmacokinetics
  • Sponsors Winston Laboratories
  • Most Recent Events

    • 16 Jun 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 24 Apr 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
    • 24 Apr 2009 Planned end date changed from 1 Feb 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top